跳转至内容
Merck
  • MicroRNA-185 reduces the expression of hepatitis B virus surface antigen by targeting PRKCH in HepG2 2.2.15 cells.

MicroRNA-185 reduces the expression of hepatitis B virus surface antigen by targeting PRKCH in HepG2 2.2.15 cells.

Acta virologica (2020-09-29)
Ronghua Zhang, Zhangxinyi Liu, Xiaoli Hou, Meimei Wang, Yanan Xiong, Hongjian Lu, Yitong Wang, Jinghui Su, Yutan Liu, Guangling Zhang, Yakun Liu
摘要

MicroRNAs (miRNAs) are single-stranded noncoding RNAs with 18 to 25 nucleotides and play critical roles in a wide spectrum of biological processes. We repored that miR-185 inhibited hepatitis B surface antigen (HBsAg) expression and hepatitis B virus (HBV) replication without affecting the proliferation of HepG2 2.2.15 cells, compared with the controls. We identified that protein kinase C eta (PRKCH) is a direct target gene of miR-185 that affects HBV replication and protein expression and that the miR-185 may suppress HBV replication. Our results provide more information for gene therapy in HBV infection. Keywords: miR-185; HBV; HBV surface antigen; viral replication; PRKCH.

材料
货号
品牌
产品描述

Sigma-Aldrich
吩嗪硫酸甲酯
Sigma-Aldrich
MISSION® esiRNA, targeting human PRKCH